Videos

Featured

Broadcast

Prevention & Chronic Conditions

Heart Failure
Breakthrough Mineralocorticoid Receptor Agonists in Cardiovascular Care

Vijay Chopra, Javed Butler, Dinesh Khullar , et al

Watch time: 1h 4m 2s

Nir Uriel

Watch time: 34m 39s (5 videos)
The Future of Heart Failure With Dr Yancy

Clyde W Yancy

Watch time: 9m 15s

Jasper J Brugts

Watch time: 2m 59s (15 videos)
AHA 25: HFpEF as an Adipose Tissue Disorder

Milton Packer

Watch time: 5m 43s
AHA 25 Late-breaking Discussion: Analysis from the SURPASS-CVOT Trial

Harriette Van Spall, Stephen Nicholls

Watch time: 12m 43s
AHA 25: The POLY-HF Trial

Ambarish Pandey

Watch time: 4m 15s
ESC 25 Hot Line Discussion: VICTOR: Vericiguat in Heart Failure

Harriette Van Spall, Faiez Zannad

Watch time: 13m 4s
ESC HF 25: The VELOCITY Study

Stephen J Greene

Watch time: 5m 30s
ESC 25: The REBOOT-CNIC Trial

Borja Ibanez

Watch time: 3m 53s
AHA 25: MAPLE-HCM Responder Analysis

Andrew Wang

Watch time: 3m
EASD 2019: EXSCEL - Dr Lindsay E Clegg

Watch time: 6m 1s
DAPA-HF: A discussion with the trialist

John JV McMurray, Mikhail Kosiborod

Watch time: 19m 18s
AHA 2019: Updates from the DAPA-HF trial — Dr Harriette Van Spall and Dr Mikhail N Kosiborod

Harriette Van Spall, Mikhail Kosiborod

Watch time: 7m 44s
DAPA-HF Background Therapy

Mikhail Kosiborod, Mark Petrie

Watch time: 25m 36s
HFA 2020: Eligibility for sacubitril/valsartan in HF across the EF spectrum

Gianluigi Savarese

Watch time: 7m 56s
ESC 2020 Discussion: The PARALLAX Trial

Harriette Van Spall,

Watch time: 22m 32s
HFSA 2020: Primary HELP Trial Results - Dr Barry A Borlaug

Barry Borlaug

Watch time: 7m 58s
Cardiomyopathy in perspective

William Bradlow

Watch time: 26m 2s
ACC 2021 Discussion: Benefits of SGLT1/2 Inhibition Across the Full Spectrum of EF, Including HFpEF

Deepak L Bhatt, Harriette Van Spall

Watch time: 16m 6s
The PRESERVED-HF Study

Mikhail Kosiborod

Watch time: 12m 4s
AHA 21: Results From Rose Clinical Trial CETPi Lowers LDL-C in Patients Taking High Intensity Statins

Stephen Nicholls

Watch time: 5m 41s
EMPATROPISM FE: Effects of Empagliflozin on iron metabolism in non-diabetic

Christiane Angermann

Watch time: 22m 15s
ACC 2022 Late-breaker Discussion: The SODIUM-HF Trial

Justin Ezekowitz, Harriette Van Spall

Watch time: 16m 42s
HF 22: CLOROTIC: Combined Loop With Thiazide Diuretics in Pts With Decompensated HF

Watch time: 4m 19s
APSC Journal Club: Landmark Trials of SGLT2 Inhibitors in HFrEF

Jack Tan Wei Chieh, Jonathan Jiunn Liang Yap, Wishnu Aditya, et al

Watch time: 1h 18m 6s
ESC 22 Late-breaker Discussion: The REVIVED Trial

Divaka Perera, Harriette Van Spall

Watch time: 14m 31s